Joella Martinez
Physician Assistant · Palm Desert, CANPI 1760845382
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,372 and has fallen 97.8% since, to $31 in 2025.
Across 105 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$281
- Daiichi Sankyo Inc.$237
- Otsuka America Pharmaceutical, Inc.$237
- Biohaven Pharmaceuticals, Inc.$204
- Novartis$185
- Johnson & Johnson$157
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,513100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $281 |
| Daiichi Sankyo Inc. | 9 | $237 |
| Otsuka America Pharmaceutical, Inc. | 2 | $237 |
| Biohaven Pharmaceuticals, Inc. | 5 | $204 |
| Novartis | 9 | $185 |
| Johnson & Johnson | 3 | $157 |
| Abbott | 8 | $145 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $124 |
| Amarin Pharma, Inc. | 6 | $111 |
| Boehringer Ingelheim | 4 | $96 |
| AstraZeneca | 5 | $89 |
| Antares Pharma, Inc. | 4 | $86 |
| AbbVie | 5 | $79 |
| E.r. Squibb & Sons, L.L.C. | 3 | $56 |
| Viiv Healthcare Company | 2 | $54 |
| GSK | 4 | $53 |
| Bayer | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Lilly USA, LLC | 2 | $30 |
| Avion Pharmaceuticals | 2 | $29 |
| EMD Serono, Inc. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Amgen | 1 | $21 |
| Merck | 1 | $21 |
| Almatica Pharma LLC | 1 | $17 |
| Pfizer | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Itamar Medical Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$125
- CAPLYTA$124
- REXULTI$121
- XARELTO$120
- ABILIFY MAINTENA$116
- ABILIFY ASIMTUFII$116
- Wegovy$113
- INJECTAFER$108
How this compares
$2,513 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 25 | $206 |
| Levothyroxine Sodium | 22 | $197 |
| Hydrochlorothiazide | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Palm Desert
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
- Asma HussainiThousand Oaks$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.